|
|
Volumn 18, Issue 4, 2009, Pages 211-212
|
|
Sunitinib in breast cancer: Friend or foe
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
BEVACIZUMAB;
DOCETAXEL;
PROTEIN TYROSINE KINASE INHIBITOR;
SUNITINIB;
TAXANE DERIVATIVE;
VASCULOTROPIN INHIBITOR;
ANOREXIA;
ANTIANGIOGENIC THERAPY;
ANTINEOPLASTIC ACTIVITY;
ARTHRALGIA;
BREAST CANCER;
CANCER CHEMOTHERAPY;
CLINICAL TRIAL;
DIARRHEA;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG TOLERABILITY;
EDITORIAL;
FATIGUE;
FEBRILE NEUTROPENIA;
FLUID RETENTION;
GASTROINTESTINAL SYMPTOM;
HAND FOOT SYNDROME;
HUMAN;
HYPERURICEMIA;
LIVER FUNCTION TEST;
METASTASIS;
MUCOSA INFLAMMATION;
MULTIPLE CYCLE TREATMENT;
MYALGIA;
NAIL;
NAUSEA;
NEUROPATHY;
NEUTROPENIA;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
QUALITY OF LIFE;
SIDE EFFECT;
ANGIOGENESIS INHIBITORS;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
FEMALE;
HUMANS;
INDOLES;
PYRROLES;
TAXOIDS;
|
|
EID: 69749108227
PISSN: 09609776
EISSN: None
Source Type: Journal
DOI: 10.1016/j.breast.2009.07.006 Document Type: Editorial |
|
Times cited : (2)
|
|
References (4)
|
